By Walt Hickey Liking Numlock? Forward today’s email to a friend you think may enjoy it and might subscribe. Germs AOBiome Therapeutics wants to be the first to score FDA approval to sell pharmaceutical-grade topical live bacteria to treat skin problems like acne, eczema, rosacea and hay fever. It’s a bold pitch: make an uneasy peace with humanity’s ancient foe, bacteria, to confront humanity’s true enemy, looking less pretty than we would otherwise prefer. I can get behind such a truce, and apparently so can investors: equity funding for companies working in microbiomes was $173 million in 2015 and jumped to $728 million a year later, hitting
But hey, climate change is fake. The Republicans keep saying so, and why would they lie?